Vical and Bristol-Myers Ink Deal – Analyst Blog

By | September 17, 2012
0 Comment

Vical Incorporated ( VICL ) recently signed an agreement with Bristol-Myers Squibb Company ( BMY ) providing the latter with a global, non-exclusive license to its patented platform

Read More:
Vical and Bristol-Myers Ink Deal – Analyst Blog

Related posts:

  1. Life Partners with Bristol-Myers – Analyst Blog
  2. Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 02, 2013
  3. Stock Upgrades: Bristol-Myers Is Just What the Doctor Ordered
  4. Erickson, Pacific Sign 1-year Deal – Analyst Blog